Silica nanoparticles in targeted human cancer therapy
Authors
Hesham Mohamed Abdal-Salam Yehia
Department of Biotechnology, HST Company, Cairo, Egypt
Said Mahmoud Said
Department of Biotechnology, HST Company, Cairo, Egypt
Noheer Galal Elden Rashad Ragb
Faculty Member at Fayoum University, Fayoum University, Fayoum, Egypt
DOI: https://doi.org/10.2478/acb-2022-0002 | Journal eISSN: 2544-3577
Language: English
Page range: 7 - 17
Submitted on: Jan 28, 2022
Accepted on: Mar 2, 2022
Published on: Apr 10, 2022
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2022 Hesham Mohamed Abdal-Salam Yehia, Said Mahmoud Said, Noheer Galal Elden Rashad Ragb, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.